Labor & Employment Law Daily Wrap Up, AGENCY NEWS—HHS overhauls vaccine advisory panel, sparking debate over science and trust, (Jun 11, 2025)
HHS has dismissed all 17 members of the CDC's vaccine advisory committee, prompting fierce debate over scientific integrity and public trust.
In a sweeping and controversial move, HHS announced the complete reconstitution of the Advisory Committee on Immunization Practices (ACIP), the body responsible for vaccine recommendations to the CDC. Under the direction of Secretary Robert F. Kennedy, Jr., all 17 existing members (most appointed under the Biden administration) were removed and will be replaced with new appointees. In a press release, Kennedy framed the action as a critical step toward restoring public trust, arguing that the committee must be free of industry influence and fully guided by transparent, evidence-based science.
The decision was presented as part of President Trump’s “Restoring Gold Standard Science” executive order, which mandates that scientific advisory bodies be composed of experts chosen through a process deemed credible and impartial by the administration. Kennedy emphasized that this move is not about being “pro- or anti-vaccine,” but rather about ensuring that decisions are grounded in unbiased science, free from conflicts of interest.
However, critics from both political and medical communities voiced strong opposition. Senator Bernie Sanders called the firings “dangerous and unprecedented,” accusing the administration of undermining vaccine safety and spreading misinformation. Representative Frank Pallone, Jr. went further, alleging the panel would now be stacked with anti-vaccine advocates, putting public health, particularly children's health, at risk. Leading physicians and public health experts warned that the dismissal of ACIP members destabilizes a trusted institution that has been instrumental in curbing diseases through effective vaccination campaigns.
Many experts fear the move marks a political intrusion into scientific processes and could erode long-standing public confidence in U.S. vaccine policy. Former ACIP members and public health organizations highlighted the committee’s successful track record, citing significant reductions in diseases like rotavirus, cervical cancer, and RSV hospitalizations. They argue that removing the panel en masse disrupts a system that has historically upheld rigorous, evidence-based medicine. With ACIP's next meeting scheduled for late June, attention now turns to the identities and qualifications of its new members, and the direction the committee will take under its reconstituted leadership.
News: AgencyNews Covid19 PublicEmployees Safety Discharge WhiteHouseNews